Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-07

Clinical Trial Update: RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression [Phase 2]

View source ↗

Summary

Phase 2 trial update of RAD001 in advanced gastric cancer after failure of first-line therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RAD001 (everolimus)

Snippet

Sponsor: Asan Medical Center | Conditions: Stomach Neoplasm | Phase 2 | Status: COMPLETED